AMA stumps for health bill on YouTube

Share this article:
The American Medical Association (AMA) reasserted its support for America's Affordable Health Choices Act of 2009 (H.R. 3200) in a YouTube video starring AMA president James Rohack, a cardiologist from Texas.

In the video, Rohack describes AMA's position as one that supports “pluralism, freedom of choice, freedom of practice and universal access for patients.” After a “thorough review of H.R. 3200,” the AMA announced its support for health reform legislation in the House.

Rohack goes on to name three specific points in the legislation: the provision of health insurance coverage for 97% of Americans, the elimination of coverage denials based on pre-existing conditions and the repeal of the Medicare physician payment formula.

Acknowledging that the “debate is far from over,” Rohack says AMA will push for medical liability reform from a place at the table, before signing off with a statement to physicians (“together we are stronger”) and patients (“we're working to make the healthcare system better for you”).
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...